Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyMeta-analysisPublished in a peer-reviewed journal

Prevalence of Schizophrenia and Bipolar Disorder in Multiple Sclerosis (Human Study)

A meta-analysis found that the prevalence of schizophrenia (SCZ) in people with multiple sclerosis (MS) was 0.61%, while the prevalence of bipolar disorder (BD) was 3.34%. Prevalence rates varied based on factors such as disease stage, disability level, sex ratio, and geographic location, with higher rates reported in the Americas and Europe. The study period also influenced these prevalences.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
Moderate
Outcome
Not reported

Why it matters

Understanding the prevalence of SCZ and BD in MS patients is crucial for improving mental health support and healthcare planning. Variations by sex and disease stage suggest the need for tailored interventions.

What this does not prove

The study emphasizes the necessity for standardized assessments and additional research to refine these prevalence estimates.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Meta-analysis
Participants / samples
Not reported
Randomised
Not applicable
Controlled
Not applicable
Primary endpoint met
Not applicable
Relevant MS type
All
Publication date
2026-10-19
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
Not reported
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (11)
subjectsOur aim was to determine the global pervasiveness of SCZ and BD in people with MS.
peer reviewedPublication types: Journal Article
relevant ms typesThe prevalence of BD was higher in people with early-stage MS or moderate disability and varied by sex ratio.
publication datePublication date: 2026-10-19
findingsThe pooled prevalence of SCZ in people with MS was 0.61% (95% CI, 0.25%-1.11%), and BD was 3.34% (95% CI, 2.04%-4.91%).
limitationsThese findings highlight the need for standardized assessments and further studies.
study designTitle: The Prevalence of Schizophrenia and Bipolar Disorder in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
study phaseTitle: The Prevalence of Schizophrenia and Bipolar Disorder in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
randomizedTitle: The Prevalence of Schizophrenia and Bipolar Disorder in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
controlledTitle: The Prevalence of Schizophrenia and Bipolar Disorder in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
primary endpoint metTitle: The Prevalence of Schizophrenia and Bipolar Disorder in Multiple Sclerosis: A Systematic Review and Meta-Analysis.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.